SARTORIUS STEDIM BIOTECH (DIM.PA) Earnings History & Surprises

EPA:DIM • FR0013154002

168.65 EUR
+1.6 (+0.96%)
Last: Mar 4, 2026, 10:07 AM

Past quarterly earnings results for SARTORIUS STEDIM BIOTECH (DIM.PA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateN/A
PeriodQ1 / 2026
EPS Estimate€1.27
Revenue Estimate765.39M

Last Reported

Most Recent
Release DateFeb 3, 2026
PeriodQ4 / 2025
EPS Reported€1.12
EPS Surprise -12.72%
Revenue Surprise -4.17%

Beat Rate

Last 8 Quarters
50%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (EUR)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 1.12 1.28 -12.72% 8.74% 772.2M 805.83M -4.17% 2.78%
Q3 2025 0.94 0.96 -2.24% 23.68% 705.7M 734.65M -3.94% 7.67%
Q2 2025 1.18 1.07 10.22% 38.82% 745M 742.74M 0.30% 5.46%
Q1 2025 1.16 0.95 22.18% 34.88% 744.6M 719.3M 3.52% 11.65%
Q4 2024 1.03 0.96 7.63% 43.06% 751.3M 730.06M 2.91% 6.30%
Q3 2024 0.76 0.81 -5.62% -10.59% 655.4M 690.73M -5.11% -1.72%
Q2 2024 0.85 1.07 -20.27% -28.57% 706.4M 696.1M 1.48% 4.54%
Q1 2024 0.86 0.95 -9.42% -39.86% 666.9M 726.14M -8.16% -8.15%
Q4 2023 0.72 0.85 -15.13% -65.05% 706.8M 659.45M 7.18% -20.58%
Q3 2023 0.85 2.81 -69.78% -61.01% 666.9M 723.67M -7.84% -24.08%
Q2 2023 1.19 2.15 -44.76% -45.66% 675.7M 709.53M -4.77% -21.59%
Q1 2023 1.43 1.44 -0.76% -35.29% 726.1M 733.36M -0.99% -15.81%
Q4 2022 2.06 2.17 -5.05% 6.19% 890M 917.58M -3.01% 14.37%
Q3 2022 2.18 3.05 -28.54% 7.39% 878.4M 906.82M -3.13% -58.35%
Q2 2022 2.19 3.27 -33.08% 18.38% 861.8M 883.44M -2.45% 23.70%
Q1 2022 2.21 2.79 -20.84% 34.76% 862.5M 787.82M 9.48% 31.64%
Q4 2021 1.94 1.83 5.83% 70.18% 778.177M 755.82M 2.96% 46.64%
Q3 2021 2.03 1.85 9.83% 69.17% 2.109B 703.67M 199.69% 313.17%
Q2 2021 1.85 1.57 18.17% 94.74% 696.7M 670.5M 3.91% 55.86%
Q1 2021 1.64 1.46 11.98% 88.51% 655.2M 584.79M 12.04% 55.22%
Q4 2020 1.14 1.09 4.70% - 530.681M 490.04M 8.29% -
Q3 2020 1.20 0.95 25.73% - 510.4M 456.85M 11.72% -
Q2 2020 0.95 0.91 4.28% - 447M 454.6M -1.67% -
Q1 2020 0.87 0.77 13.71% - 422.1M 403.42M 4.63% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

DIM.PA EPS Q2Q GrowthDIM.PA EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 0 50 -50

Revenue Historical Q2Q growth and Acceleration

DIM.PA Revenue Q2Q GrowthDIM.PA Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 0 100 200 300

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
9.45%
Max EPS beat (4)
22.18%
Min EPS beat (4)
-2.24%

Revenue beat statistics

Revenue beat (4)
3
Average Revenue beat (4)
0.70%
Max Revenue beat (4)
3.52%
Min Revenue beat (4)
-3.94%

Analysis

In the last 4 quarters, DIM.PA has beaten EPS estimates in 3 out of 4 releases
DIM.PA has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, DIM.PA has beaten the EPS estimates by 9.4% on average.
In the last 4 quarters, DIM.PA has beaten the revenue estimates by 0.7% on average.
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

SARTORIUS STEDIM BIOTECH / DIM.PA Earnings FAQ

What is the most recent earnings date for DIM stock?

SARTORIUS STEDIM BIOTECH (DIM.PA) last reported earnings on 2/3/2026.


Did SARTORIUS STEDIM BIOTECH (DIM.PA) beat earnings estimates last quarter?

SARTORIUS STEDIM BIOTECH (DIM.PA) missed EPS estimates and missed revenue estimates in the most recent quarter.


What percentage of the time does DIM stock beat earnings estimates?

In the last 4 quarters, SARTORIUS STEDIM BIOTECH (DIM.PA) has beaten EPS estimates in 3 out of 4 releases.